Publications found:
1,234
Sort by:
AI Tumor Evolution Maps Market Forecasts to 2032 – Global Analysis By Cancer Type (Brain Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Pancreatic Cancer, Hematologic Malignancies, Rare & Pediatric Cancers and Other Cancer Types), Technology, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global AI Tumor Evolution Maps Market is accounted for $196.03 million in 2025 and is expected to reach $1390.77 million by 2032 growing at a CAGR of 32.3% during the...
September 2025
200 pages
Radioligand Therapy (RLT) Market by Product (Lutetium-177 Vipivotide Tetraxetan, (Lu-177)- PNT2002, Radium-223 dichloride), Target (PSMA, SSTR, Bone Metastases), Indication (Prostate Cancer, Neuroendocrine Tumors (NETS), SCLC) - Global Forecast to 2035
US$ 2,970.00
The global radioligand therapy market is projected to reach USD 10.91 billion by 2035 from an estimated USD 3.15 billion in 2025, at a CAGR of 13.2% during the forecast period. The growth of the radio...
September 2025
313 pages
Secondary Myelofibrosis Market - 2024-2031
US$ 3,400.00
Secondary Myelofibrosis Marketis is growing with a CAGR of 6.00% during the forecast period 2026-2035. The Secondary Myelofibrosis Market emerges as a key focus in DataM Intelligence latest in-depth a...
September 2025
49 pages
Targeted Alpha Therapies for Cancer Treatment: Global Market
US$ 2,950.00
Report The report provides an overview of the global market for targeted alpha therapies (TAT) for cancer and analyzes market trends. It includes global revenue ($ million) for the base year data 2024...
September 2025
81 pages
Breast Cancer Therapeutics Market - 2024-2033
US$ 3,400.00
Breast Cancer Therapeutics Market reached US$ 37.75 Billion in 2024 and is expected to reach US$ 72.05 Billion by 2033, growing with a CAGR of 9.40% during the forecast period 2026-2033. The Breast Ca...
September 2025
52 pages
NUT Midline Carcinoma Treatment Market Forecasts to 2032 – Global Analysis By Treatment Type (Chemotherapy, Targeted Therapy, Radiation Therapy, Immunotherapy, and Surgery), Route of Administration, Technology, Drug Class, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global NUT Midline Carcinoma Treatment Market is accounted for $24.99 billion in 2025 and is expected to reach $73.25 billion by 2032 growing at a CAGR of 16.6% durin...
September 2025
200 pages
Skin Cancer Treatment Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Melanoma and Non-Melanoma); Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy, and Others); End User (Hospitals, Dermatology Clinics, Diagnostic and Cancer Care Centers, and Others); and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)
US$ 4,450.00
The skin cancer treatment market size is projected to rise from US$11.79 billion in 2024 to reach US$19.53 billion by 2031. The market is expected to register a CAGR of 7.57% from 2025 to 2031. Major...
September 2025
241 pages
Global Cancer Biomarker Market - 2026-2032
US$ 3,400.00
Global Cancer Biomarker Market reached USD 13.2 billion in 2022 and is expected to reach USD 32.5 billion by 2031, growing with a CAGR of 12.30% during the forecast period 2026-2031. The Global Cancer...
September 2025
49 pages
Breast Implants Market - 2025-2033
US$ 3,400.00
Breast Implants Market reached US$ 1.88 billion in 2024 and is expected to reach US$ 3.34 billion by 2033, growing with a CAGR of 6.60% during the forecast period 2026-2033. The Breast Implants Market...
September 2025
41 pages
Cancer Immunotherapy Market - 2026-2033
US$ 3,400.00
Cancer Immunotherapy Market reached US$ 137.70 billion in 2024 and is expected to reach US$ 261.74 billion by 2033, growing with a CAGR of 7.90% during the forecast period 2026-2033. The Cancer Immuno...
September 2025
46 pages
Global Cancer/Tumor Profiling Market Size study & Forecast, by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Other Cancer), Biomarker Type (Genomic Biomarker and Protein Biomarker), Technology, Technique, Application and Regional Forecasts 2025-2035
US$ 3,750.00
... – 2019 to 2026 Target Audience of the Global Cancer/Tumor Profiling Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value ...
September 2025
285 pages
Acute Myeloid Leukemia Therapeutics Market Report by Treatment Type (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-Metabolites, Tyrosine Kinase Inhibitors, and Others), Drug Type (Small Molecule Drugs, Biopharmaceuticals), Route of Administration (Oral, Injectables), and Region 2025-2033
US$ 2,999.00
The global acute myeloid leukemia therapeutics market size reached USD 1,343.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 3,461.4 Million by 2033, exhibiting a growt...
September 2025
144 pages
Hematologic Malignancies Market Report by Type (Leukemia, Lymphoma, Multiple Myeloma, and Others), Therapy (Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others), End User (Hospitals, Diagnostics Centers, Research Centers, and Others), and Region 2025-2033
US$ 2,999.00
The global hematologic malignancies market size reached USD 65.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 129.5 Billion by 2033, exhibiting a growth rate (CAGR) of...
September 2025
143 pages
Lymphoma Treatment Market Report by Type (Hodgkin Lymphoma, Non-Hodgkin Lymphoma), Test Type (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Biologic Therapy, and Others), Drug (Adcetris, Rituxan, Opdivo, Imbruvica, Keytruda, Revlimid, and Others), and Region 2025-2033
US$ 2,999.00
The global lymphoma treatment market size reached USD 14.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 27.4 Billion by 2033, exhibiting a growth rate (CAGR) of 7.13%...
September 2025
139 pages
U.S. Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories), And Segment Forecasts, 2025 - 2033
US$ 5,950.00
U.S. Liver Cancer Diagnostics Market Trends The U.S. liver cancer diagnostics market size was estimated at USD 3.14 billion in 2024 and is projected to reach USD 4.44 billion by 2033, growing at a CAG...
August 2025
150 pages
Middle East Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), By End-Use, By Country, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Market Size & Trends The Middle East liver cancer diagnostics market size was estimated at USD 268.10 million in 2024 and is projected to reach USD 466.42 million by 2033, growing at a CAGR of 6.35% f...
August 2025
150 pages
Colorectal Cancer Treatment Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment (Surgery, Chemotherapy, Immunotherapy, Targeted Therapy, and Others), Age Group (Below 49 Years, 50 - 64 Years and Above 65 Years), End Users (Hospitals, Specialty Clinics, Home Care, and Others), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South and Central America)
US$ 4,450.00
The colorectal cancer treatment market is projected to reach US$24.74 billion by 2031 from US$19.93 billion in 2024. The market is estimated to register a CAGR of 3.2% during 2025-2031. Major factors...
August 2025
241 pages
Cancer Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer, and Others), By Indication (Breast Cancer, Ovarian Cancer, Lung Cancer, Liver Cancer, Pancreatic Cancer, Prostate Cancer, and Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, and Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Cancer Gene Therapy Market was valued at USD 4.52 billion in 2024 and is expected to reach USD 13.58 billion by 2030 with a CAGR of 20.12% during the forecast period. The globa...
August 2025
185 pages
Stomach Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy, Others), By Cancer Type (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal Tumors), By Route of Administration (Oral, Injectables), By Drug Class (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Stomach Cancer Treatment Market was valued at USD 5.51 billion in 2024 and is expected to reach USD 12.64 billion by 2030 with a CAGR of 14.84% during the forecast period. The...
August 2025
185 pages
Middle East AI In Oncology Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Application, By End-use, By Country, And Segment Forecasts, 2025 - 2033
US$ 4,950.00
Middle East AI in Oncology Market Trends The Middle East AI in oncology market size was estimated at USD 111.33 million in 2024 and is projected to grow at a CAGR of 21.94% from 2025 to 2033. The risi...
August 2025
100 pages
U.S. Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Market Size & Trends The U.S. oncology based molecular diagnostics market size was estimated at USD 1.49 billion in 2024 and is expected to grow at a CAGR of 5.2% from 2025 to 2033. Key market driving...
August 2025
136 pages
Global PD-L1 Testing and Therapeutics Market - 2025-2033
US$ 3,400.00
Global PD-L1 Testing and Therapeutics Market reached US$ 52.05 billion in 2023 and is expected to reach US$ 159.84 billion by 2033, growing with a CAGR of 11.60% during the forecast period 2026-2033....
August 2025
63 pages
Global Basal Cell Carcinoma Treatment Market - 2024–2031
US$ 3,400.00
Global Basal Cell Carcinoma Treatment Marketis is growing with a CAGR of 9.40% during the forecast period 2026-2035. The Global Basal Cell Carcinoma Treatment Market emerges as a key focus in DataM In...
August 2025
63 pages
Alternative Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others), By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others), By End Users (Hospitals and Clinics, Cancer and Radiation Therapy Center, Home Care, Others), By Region & Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Alternative Cancer Therapeutics Market was valued at USD 15.65 billion in 2024 and is expected to reach USD 26.94 billion by 2030 with a CAGR of 9.62% during the forecast perio...
August 2025
188 pages
Chemotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Alkylating Agents, Anti-metabolites, Anti-Tumor Antibiotics, Hormones, Monoclonal Antibodies, Others), By Indication (Oncology/Cancer, Bone Marrow Diseases, Immune System Disorders, Others), By Dosage Form (Capsule, Tablets, Injections, Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospitals, Specialty Clinics, Others), By Region & Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Chemotherapy Market was valued at USD 8.26 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.51% through 2030. Cancer, as...
August 2025
180 pages
Asia Pacific Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
Market Size & Trends The Asia Pacific oncology based molecular diagnostics market size was estimated at USD 822.5 million in 2024 and is projected to reach USD 1,560.75 million by 2033, growing at a C...
August 2025
136 pages
Tumor Ablation Market - 2024-2031
US$ 3,400.00
Tumor Ablation Market reached US$ 2,079.2 million in 2031 and, growing with a CAGR of 13.10% during the forecast period 2031-2035. The Tumor Ablation Market emerges as a key focus in DataM Intelligenc...
August 2025
40 pages
Brachytherapy Market Report by Service Type (History and Physical Report, Discharge Summary, Operative Note or Report, Consultation Report, and Others (Pathology Report, Radiology Report, etc.)), Technology (EMR/EHR, PACS, RIS, SRT, and Others), Mode of Procurement (Outsourcing, Offshoring, Both), End-User (Hospitals, Clinics, Clinical Laboratories, Academic Medical Centers, and Others), and Region 2025-2033
US$ 2,999.00
The global brachytherapy market size reached USD 888.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,215.9 Million by 2033, exhibiting a growth rate (CAGR) of 3.55% d...
August 2025
149 pages
Glioblastoma Multiforme Treatment Market Report by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, and Others), Route of Administration (Oral, Parenteral), Type of Molecule (Small Molecule, Biologics), Distribution Channel (Hospitals, Pharmacies, and Others), and Region 2025-2033
US$ 2,999.00
The global glioblastoma multiforme treatment market size reached USD 2.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.1 Billion by 2033, exhibiting a growth rate (CA...
August 2025
138 pages
Multiple Myeloma Drugs Market Size, Share, Trends and Forecast by Therapy, Drug Type, End User, Distribution Channel, and Region, 2025-2033
US$ 2,999.00
The global multiple myeloma drugs market size was valued at USD 23.46 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 36.86 Billion by 2033, exhibiting a CAGR of 4.89%...
August 2025
121 pages
Breast Pump Market - 2024-2031
US$ 3,400.00
Breast Pump Marketis is growing with a CAGR of 7.50% during the forecast period 2026-2035. The Breast Pump Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned...
August 2025
37 pages
Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Oncology Based Molecular Diagnostics Market The global oncology based molecular diagnostics market size was estimated at USD 3.75 b...
July 2025
136 pages
Antibody-Drug Conjugates (ADC) Market - 2025-2033
US$ 3,400.00
Antibody-Drug Conjugates (ADC) Market reached US$ 11.96 Billion in 2024 and is expected to reach US$ 30.42 Billion by 2033, growing with a CAGR of 11.20% during the forecast period 2026-2033. The Anti...
July 2025
56 pages
Non-Small Cell Lung Cancer Therapeutics Market - 2025-2033
US$ 3,400.00
Non-Small Cell Lung Cancer Therapeutics Market reached US$21.33 billion in 2024 and is expected to reach US$64.92 billion by 2033, growing with a CAGR of 11.70% during the forecast period 2026-2033. T...
July 2025
65 pages
Esophageal Cancer Treatment Market - 2025-2033
US$ 3,400.00
Esophageal Cancer Treatment Market reached US$ 1.31 billion in 2024 and is expected to reach US$ 2.66 billion by 2033, growing with a CAGR of 8.20% during the forecast period 2026-2033. The Esophageal...
July 2025
53 pages
